Business Wire

TVCMALL brings one-stop wholesale solution to MWC 2023


Recently, the 2023 Mobile World Congress (MWC) held in Barcelona turned out to be a big success. More than 88,000 attendees and 2400+ exhibitors participated in this event, including many cell phone accessories suppliers & wholesalers. As Europe's leading one-stop shop for mobile accessories and wholesale/integrated supply chain service platform, TVCMALL participated in this digital/mobile feast. TVCMALL, based in Shenzhen China, the world's electronic center, provides the esteemed customer B2B solution on mobile accessories for wholesale, sourcing, and customization. Various classic mobile cases with leather finishing, chargers with multifunctions, and Amorus portable Karaoke speaker brought by TVCMALL were highly praised by our attendees.

This press release features multimedia. View the full release here:

To view this piece of content from, please give your consent at the top of this page.

TVCMALL brings one-stop wholesale solution to MWC 2023 (Photo: Business Wire)

MWC is one of the world's most important telecommunications & technology shows. During the past 4 days, the aspects such as the latest trend in mobile technologies, including Intelligent equipment, 5G network, AI, and digitalization, have been introduced and shared with the world.

During the show, TVCMALL met a lot of old customers and new friends. Many of them are as follows:

  1. Top online mobile phone accessories retailers & distributors
  2. B2C platform sellers, Dropshippers
  3. Offline chain stores, Supermarket sellers, Telecom companies
  4. Gift-Customize customers (especially for government, corporate & schools and other agents)
  5. OEM & ODM & OBM customers
  6. Retail shops & Mobile phone repair shops

Many customers have cooperated with TVCMALL for over ten years since its establishment in 2008, and they have grown and developed rapidly with TVCMALL. They expressed their high recognition and gratitude to TVCMALL for providing one-stop wholesale, sourcing, customized services, and other supply chain services.

Why they choose TVCMALL as an indispensable and important long-term partner? Because TVCMALL provides complete product catalog, with more than 600,000 SKU online, and every week 6,000 new products updated. Its wholesale process, marketing support, and customer service are efficient. TVCMALL has good intention of growing together with their customers.

TVCMALL's comprehensive procurement cost is relatively low, the service consistency and stability are very strong. That’s why many customers prefer one-stop service providers like TVCMALL.

During the MWC, TVCMALL has established a bridge of contact with some excellent product suppliers and e-commerce service providers (of mobile, 3C electronic devices and accessories).

In the foreseeable future, with continuously TVCMALL brand and platform upgrading, TVCMALL will strengthen its mission, "To help entrepreneurs actualize their dreams of launching and sustaining a successful retail business", and will stick to its business operation philosophy "Together we thrive". In terms of specific strategies, TVCMALL will adhere to the following 4 directions:

  1. Platform Branding — Operate the TVCMALL platform as a future century-old brand
  2. Productization of the services — all the services of TVCMALL with the idea of Productization.
  3. Product Deep ploughing — Thrive to be the best.
  4. Localization of TVCMALL service — Go global and localization: Initiate local marketing and service team, in-depth understanding & efficient service.

TVCMALL will see you again in Barcelona 2024!

To view this piece of content from, please give your consent at the top of this page.

Contact information

Shenzhen Zhenzhi Technology Co.,Ltd.
Yelly Huang

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

REGiMMUNE Limited Licenses the Rights to Develop and Commercialize RGI-2001 To San Fu Biotech in Major Asian Countries1.4.2023 19:18:00 EEST | Press release

REGiMMUNE Limited (REGiMMUNE), a biotech company focused on creating innovative immunotherapies for immune disorders and cancer, and San Fu Biotech (SFB), a subsidiary of San Fu Chemical Co., Ltd. (4755.TW) have entered a licensing agreement to develop and commercialize RGI-2001 for the prophylaxis of acute Graft-versus-host disease (aGvHD) in major Asian countries. RGI-2001, with the novel mechanism to improve existing treatments, is a potentially first-in-class small molecule drug candidate targeted for preventing aGvHD, a life-threatening complication resulting from allogeneic hematopoietic stem cell transplantation (HSCT). GvHD is a systemic disorder that occurs when the graft's immune cells recognize the host as foreign and attack the recipient’s body cells or organs, and leads to skin rash, liver problems, abdominal pain or cramps, diarrhea, and increased risk for infections. Patients undergoing allogeneic HSCT have a high-risk of developing aGVHD associated with significant morb

AriBio Co., Ltd. to Present Biomarker Data for AR1001 from the Mild to Moderate Alzheimer’s Disease Phase 2 Study at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD™ 2023)31.3.2023 19:00:00 EEST | Press release

AriBio Co., Ltd. announced that David Greeley MD, Chief Medical Officer at AriBio, will present biomarker data from the completed phase 2 study in patients with mild to moderate Alzheimer’s disease who were treated with 10mg and 30mg of AR1001. AR1001 is a potent PDE5 inhibitor with preliminary efficacy in cognition, and preclinical effects on neuron apoptosis inhibition, promotion of neurogenesis, increase in neuroplasticity, and stimulation of autophagy to remove toxic proteins. The phase 2 study was a double-blind, randomized, placebo-controlled, multi-center trial to evaluate the safety and preliminary efficacy of AR1001 over 26 and 52 weeks of treatment in patients with mild to moderate Alzheimer’s disease. The trial enrolled 210 patients at 21 research centers in the United States. Plasma collected from patients at baseline, week 26 and week 52 was analyzed by Quantarix using the Simoa HD-X analyzer. Meaningful, statistically significant changes were found over 52 weeks of treatm

KANEKA: “Development of Polymer Synthesis Technology by Microorganisms using CO2 as Direct Raw Material” selected as a NEDO Green Innovation Fund Project”31.3.2023 17:09:00 EEST | Press release

Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka; hereinafter "Kaneka"), Bacchus Bio innovation Co., Ltd (Headquarters: Kobe-city, Hyogo; President: Mikio Tanji; hereinafter "Bacchus"), JGC Holdings Corporation (Headquarters: Yokohama-city Kanagawa; Chairman and CEO: Masayuki Sato; hereinafter "JGC HD"), and Shimadzu Corporation (Headquarters: Kyoto-city, Kyoto; President: Yasunori Yamamoto; hereinafter "Shimadzu") have announced that the proposal of a joint project, “Development of Polymer Synthesis Technology by microorganisms using CO2 as direct raw material (hereinafter referred to as ‘the Project’)” had been selected by the "Green Innovation Fund Project*1 / Promotion of Carbon Recycling Using CO2 from Biomanufacturing Technology as a Direct Raw Material” as a planned implementation sponsored by the New Energy and Industrial Technology Development Organization (NEDO). This press release features multimedia. View the full release here: https://www.busine

Allianz Appoints Leadership for Allianz Commercial Key Markets31.3.2023 16:11:00 EEST | Press release

As part of the implementation of its ‘Integrated Commercial’ strategy to better serve the full Commercial segment, Allianz Group today announced the leadership for four of its largest Property and Casualty Commercial insurance markets: Australia, France, Germany and the United Kingdom. In each country, the appointed single Commercial lead will represent the integrated Allianz Commercial business and bring to the market Allianz’s full set of solutions for specialty clients, large corporates, and mid-sized companies, simplifying and enhancing the experience of clients and distribution partners. “The appointment of the regional leaders in our core Allianz Commercial markets is an important, concrete step toward realizing our new integrated model, which brings together our Mid Corporate and Large Corporate insurance business for the benefit of our clients and distribution partners,” said Chris Townsend, Member of the Allianz SE Board of Management. Townsend added, “As one face to the marke

Huawei Releases 2022 Annual Report: Steady Operations, Sustainable Survival and Development31.3.2023 12:59:00 EEST | Press release

Huawei released its 2022 Annual Report today. The company reports steady operations throughout 2022, having generated CNY642.3 billion in revenue and CNY35.6 billion in net profits. Huawei continues to strengthen investment in R&D, with an annual expenditure of CNY161.5 billion in 2022, representing 25.1% of the company's annual revenue and bringing its total R&D expenditure over the past 10 years to more than CNY977.3 billion. This press release features multimedia. View the full release here: (Photo: Huawei) "In 2022, a challenging external environment and non-market factors continued to take a toll on Huawei's operations", said Eric Xu, Huawei's Rotating Chairman, at the company's annual report press conference. "In the midst of this storm, we kept racing ahead, doing everything in our power to maintain business continuity and serve our customers. We also went to great lengths to grow the harvest – generating a steady stream

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom